Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A novel role for uroguanylin in the regulation of sodium balance
Leonard R. Forte
Leonard R. Forte
View: Text | PDF
Commentary

A novel role for uroguanylin in the regulation of sodium balance

  • Text
  • PDF
Abstract

Uroguanylin is a peptide hormone that regulates sodium excretion by the kidney when excess NaCl is consumed. A new study demonstrates that mice deficient in uroguanylin have blunted urinary sodium excretion responses to oral sodium loads in addition to elevated blood pressure (see related article beginning on page 1244). A physiological role for uroguanylin is discussed, linking the intestine and kidney in an endocrine axis for the maintenance of sodium balance.

Authors

Leonard R. Forte

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
An endocrine axis linking together the GI system and kidney via uroguany...
An endocrine axis linking together the GI system and kidney via uroguanylin produced in the stomach and/or intestine and secreted into the circulatory system. The studies of Lorenz et al. (7) support the concept that uroguanylin may play a key physiological role serving as a natriuretic hormone produced by the GI system and released into the circulatory system when excess NaCl is ingested. Atriopeptin-A (ANP), atriopeptin-B (BNP), and uroguanylin derived from the myocardium may, in some circumstances, also contribute to the natriuresis elicited by high salt loads in the postprandial state. Not shown in this model is the renal production of uroguanylin, guanylin, and atriopeptins, which could participate in intra-renal mechanisms that regulate tubular sodium transport and thus contribute to the saliuresis elicited by oral salt loads. A potential role for uroguanylin and/or guanylin in the CNS to influence the appetite for salt should also be considered in future studies. Figure modified with permission from the American Journal of Physiology (24).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts